Edition:
United States

People: Abbott Laboratories (ABT)

ABT on New York Consolidated

38.43USD
5 Dec 2016
Change (% chg)

$0.53 (+1.40%)
Prev Close
$37.90
Open
$38.11
Day's High
$38.45
Day's Low
$37.99
Volume
9,514,677
Avg. Vol
8,950,826
52-wk High
$46.22
52-wk Low
$36.00

Capek, John 

Dr. John M. Capek, Ph.D. is Executive Vice President - Ventures of the Company, effective June 1, 2015. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Basic Compensation

Total Annual Compensation, USD 1,260,000
Restricted Stock Awards, USD 1,102,130
Long-Term Incentive Plans, USD --
All Other, USD 1,403,790
Fiscal Year Total, USD 3,765,920

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 83,000 1,699,960.00
Name Fiscal Year Total

Miles White

19,401,700

Brian Yoor

3,008,220

Thomas Freyman

6,067,650

Hubert Allen

3,772,840

Stephen Fussell

5,750,460

Richard Ashley

3,640,640
As Of  30 Dec 2015